Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Praxis Precision Medicines, Inc. - Common Stock (NQ:PRAX)

168.22 -4.13 (-2.40%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 515,001
Open 170.17
Bid (Size) 150.00 (100)
Ask (Size) 178.00 (100)
Prev. Close 172.35
Today's Range 159.74 - 172.00
52wk Range 26.70 - 206.71
Shares Outstanding 44,712,538
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Praxis Precision Medicines, Inc.
Via GlobeNewswire

Performance

YTD
+111.5%
+111.5%
1 Month
+209.9%
+209.9%
3 Month
+266.2%
+266.2%
6 Month
+338.6%
+338.6%
1 Year
+123.3%
+123.3%

More News

Read More
Why Did Praxis Precision Medicines Stock Surge 69% In Pre-Market Today?
Via Stocktwits
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Praxis announces accelerated development path for relutrigine in SCN2A and SCN8A DEE patients following positive FDA feedback
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Meet the Biotech Stock That Just Jumped 251% Higher
Via The Motley Fool
Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday
Via Benzinga
Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Praxis Precision Stock Extends Rally Premarket As Wall Street Turns Hyper-Bullish After Essential Tremor Trial Win
Via Stocktwits
Topics Death
Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Dips Over 100 Points; US Crude Oil Inventories Surge
Via Benzinga
Topics Stocks
The 'Groundbreaking' Results That Sent Praxis Precision Medicines Up 200%
Via Investor's Business Daily
Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Praxis Precision Medicines Stock Doubles - Here's Why
Via Benzinga
Praxis Precision Medicines Announces Positive Topline Results from Two Pivotal Phase 3 Studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Praxis Precision Medicines, Inc. on Behalf of Praxis Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAX
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is Praxis Precision Medicines, Inc. - Common Stock publicly traded?
Yes, Praxis Precision Medicines, Inc. - Common Stock is publicly traded.
What exchange does Praxis Precision Medicines, Inc. - Common Stock trade on?
Praxis Precision Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Praxis Precision Medicines, Inc. - Common Stock?
The ticker symbol for Praxis Precision Medicines, Inc. - Common Stock is PRAX on the Nasdaq Stock Market
What is the current price of Praxis Precision Medicines, Inc. - Common Stock?
The current price of Praxis Precision Medicines, Inc. - Common Stock is 168.22
When was Praxis Precision Medicines, Inc. - Common Stock last traded?
The last trade of Praxis Precision Medicines, Inc. - Common Stock was at 11/07/25 04:00 PM ET
What is the market capitalization of Praxis Precision Medicines, Inc. - Common Stock?
The market capitalization of Praxis Precision Medicines, Inc. - Common Stock is 7.52B
How many shares of Praxis Precision Medicines, Inc. - Common Stock are outstanding?
Praxis Precision Medicines, Inc. - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
Copyright © 1995-2016 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.